2.19 USD
▲0.00+1.86%
盘后 2.21 +2.79%
2026-08-03
市值
$441.34M
市盈率
—
EPS
-0.04
股息率
—
52 周区间
1.15 – 3.47
成交量
6.26M
Beta
1.77
目标价
4.50
52W 低 1.1552W 高 3.47
价格走势
公司简介
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma do...